Cannabinoid Receptor 1 Antagonism Demonstrates High Therapeutic Potential for the Treatment of Primary Sclerosing Cholangitis

Simple item page
dc.contributor.authorKennedy, Lindsey
dc.contributor.authorAlpini, Gianfranco
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2023-06-15T15:58:02Z
dc.date.available2023-06-15T15:58:02Z
dc.date.issued2022
dc.eprint.versionFinal published versionen_US
dc.identifier.citationKennedy L, Alpini G. Cannabinoid Receptor 1 Antagonism Demonstrates High Therapeutic Potential for the Treatment of Primary Sclerosing Cholangitis. Cell Mol Gastroenterol Hepatol. 2022;13(4):1259-1260. doi:10.1016/j.jcmgh.2022.01.009en_US
dc.identifier.urihttps://hdl.handle.net/1805/33786
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.jcmgh.2022.01.009en_US
dc.relation.journalCellular and Molecular Gastroenterology and Hepatologyen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0*
dc.sourcePMCen_US
dc.subjectSclerosing cholangitisen_US
dc.subjectCannabinoid receptorsen_US
dc.subjectInflammationen_US
dc.subjectFibrogenesisen_US
dc.titleCannabinoid Receptor 1 Antagonism Demonstrates High Therapeutic Potential for the Treatment of Primary Sclerosing Cholangitisen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
main.pdf
Size:
199.48 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Medicine Works